VANI — Vivani Medical Income Statement
0.000.00%
- $69.27m
- $39.62m
Annual income statement for Vivani Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.38 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 1.23 | 0.5 | 0.13 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 37.3 | 14.9 | 8.93 | 14.4 | 27 |
Operating Profit | -34 | -14.9 | -8.93 | -14.4 | -27 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -33.6 | -14.9 | -8.92 | -13.9 | -25.7 |
Net Income After Taxes | -33.6 | -14.9 | -8.92 | -13.9 | -25.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -33.6 | -14.9 | -8.92 | -13.9 | -25.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -33.6 | -14.9 | -8.92 | -13.9 | -25.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -6.17 | -1.74 | -0.816 | -0.543 | -0.504 |